Drug Type Chemical drugs |
Synonyms zinc-green tea extract-ascorbic acid |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaZn |
InChIKeyHCHKCACWOHOZIP-UHFFFAOYSA-N |
CAS Registry7440-66-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Respirovirus Infections | Phase 2 | United States | 21 Sep 2022 | |
| Viral respiratory infection | Phase 2 | United States | 21 Sep 2022 |
Phase 2 | 17 | (Zinc-green Tea Extract-ascorbic Acid) | ydepbguqhr(vvslfdwwyr) = tccgmlnyed bkctjbbzkw (qivrfahepa, vzzcnzyhxv - fkuczzlgsw) View more | - | 07 Mar 2025 | ||
Placebo (Placebo) | ydepbguqhr(vvslfdwwyr) = cvarjinbuw bkctjbbzkw (qivrfahepa, cfouyckegh - kdpdmnczji) View more |





